Glioma
Conditions
Interventions
Gold Standard:HE stained specimen sections
Index test:Hyperspectral imaging, HSI
Sponsors
Tangdu Hospital, Fourth Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-70 years old, gender unlimited; (2) glioma patients to be treated by surgery. (3) Subjects voluntarily participate in this study and sign informed consent, and can understand and comply with the requirements of the study.
Exclusion criteria
Exclusion criteria: (1) Unable to perform MRI scanning and other imaging examinations; (2) Heart failure of grade III and IV (NYHA grade), unstable angina pectoris, acute myocardial infarction, persistent and clinically significant arrhythmia occurred within 6 months before enrollment; (3) Major surgery (excluding glioma surgery) was performed within 4 weeks before enrollment; Those who had bone marrow biopsy, open biopsy and intracranial biopsy within 7 days before screening; And other patients with high-risk factors for bleeding (4) Pregnant or lactating women, or those who plan to become pregnant during the study period; (5) Those who participated in other clinical trials within 30 days before enrollment; (6) The investigator judged that it was not suitable to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boundary accuracy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Survival time;Progression-Free Survival;Karnofsky Performance Status;Quality of Life score (EORTC QLQ-C30 and EORTC QLQ-BN20); | — |
Countries
China
Contacts
Public ContactWang Yuan
Tangdu Hospital, Airforce Medical University
Outcome results
None listed